参考文献

[1]安敏，张振玉，非甾体类抗炎药相关性肠病 [J]，世界华人消化杂志，2009，17（2）：174-180，

[2]张小晋，非甾体抗炎药与胃肠道疾病 [J]，世界华人消化杂志，2008，16（27）：3021-3025，

[3]John LWallace,Mechanisms,prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy[J],World JGastroenterol,2013,19(12):1861-1876,

[4]Sung Chul Park,Hoon Jai Chun,Chang Don Kang,et al,Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury[J],World JGastroenterol,2011,17(42):4647-4653,

[5]John L,Wallace,Stephanie Syer,Emmanuel Denou,et al,Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis[J],Gastroenterology,2011,141:1314-1322,

[6]John LWallace,NSAID gastropathy andenteropathy:distinctpathogenesis likely necessitates distinctprevention strategies[J],British Journal of Pharmacology,2012,165:67-74,

[7]Fujita T,Kutsumi H,Sanuki T,etal,Adherence to the preventive strategies for Nonsteroidal anti-inflammatory drug or low-dose aspirin-induced gastrointestinal injuries[J],J Gastroenterol,2013,48(5):559-73,(https://www.daowen.com)

[8]Bj rklund M,Ouwehand AC,Forssten SD,et al,Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol[J],Age,2012,34(4):987-99,

[9]Mallen SR,Essex MN,Zhang R,Gastrointestinal tolerability of NSAIDs in elderly patients:a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs[J],Curr Med Res Opin,2011,27(7):1359-66,

[10]Watanabe T,Tanigawa T,Nadatani Y,et al,Risk factors for severe non -steroidal antiinflammatory drug-induced small intestinal damage[J],Dig Liver Dis,2013,45(5):390-5,

（虎月燕 白松 白俊云 王文学）